As of 2024-12-13, the Relative Valuation of Rain Therapeutics Inc (RAIN) is (43.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.21 USD, the upside of Rain Therapeutics Inc based on Relative Valuation is -3701.4%.
The range of the Relative Valuation is (39.82) - (47.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 30.4x | 27.2x |
| Forward P/E multiples | 24.9x - 29.7x | 27.3x |
| Fair Price | (39.82) - (47.49) | (43.58) |
| Upside | -3390.8% - -4025.2% | -3701.4% |
| Date | P/E |